| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/18/2005 | CN1615844A Development of micro particle silybum marianum preparation |
| 05/18/2005 | CN1615842A Preparation for treating allergic rhinitis and asthma |
| 05/18/2005 | CN1615841A Taxinol-sodium alginate micro ball vascular embolism agent and its preparation |
| 05/18/2005 | CN1615840A Sodium camsylate freeze-dried powder injection preparation and its preparing method |
| 05/18/2005 | CN1615839A Utilization of dialkylfumarates |
| 05/18/2005 | CN1615838A Composition containing dicaffeoyl quinic acid and its preparing method |
| 05/18/2005 | CN1615837A Emulsion containing dicaffeoyl quinic acid and its preparing method |
| 05/18/2005 | CN1615836A Rubidate soft capsule and its preparing method |
| 05/18/2005 | CN1615835A 硫普罗宁软胶囊 Tiopronin soft capsules |
| 05/18/2005 | CN1615834A Non injection medicament containing new sodium houttuyfonate |
| 05/18/2005 | CN1615832A Ritodrine hydrochloride powder injection and preparing method |
| 05/18/2005 | CN1615831A Pseudoephedrine hydrochloride dripping pill |
| 05/18/2005 | CN1615830A Amfepramone hydro chloride dripping pill |
| 05/18/2005 | CN1615828A Garlicin injection emulsion and its preparing method |
| 05/18/2005 | CN1615827A Medicinal powder injection for respiratory system and preparing method |
| 05/18/2005 | CN1615826A Guaiamar dripping pill |
| 05/18/2005 | CN1615825A Poly unit slow release preparation |
| 05/18/2005 | CN1615824A Method for preparing oil soluble medicine slow releade micro ball |
| 05/18/2005 | CN1615823A Nose spray agent |
| 05/18/2005 | CN1615822A Fat milk transfusion fluid for treating pulmonary heart disease and energy supplement and its producing method |
| 05/18/2005 | CN1615821A Embolism agent |
| 05/18/2005 | CN1202127C Immunostimulant bacterial membrane tractions in cancer treatment |
| 05/18/2005 | CN1201822C Compositions comprising sympathomimetic amine salts unsuitable for illegal use |
| 05/18/2005 | CN1201821C Stable complex of insoluble chemical compound |
| 05/18/2005 | CN1201815C Stabilizer for recombinant alpha-interferon liquid |
| 05/18/2005 | CN1201811C Chinese medicine composition for treating myopia and preparing method thereof |
| 05/18/2005 | CN1201810C Chinese medicine for treating impotence |
| 05/18/2005 | CN1201809C Preparation of Chinese herbal medicine for removal of urinary calculus |
| 05/18/2005 | CN1201808C Chinese medicinal pill preparation for treating chronic colonitis |
| 05/18/2005 | CN1201807C Quick acting external ointment for treating injury and gall and preparing method thereof |
| 05/18/2005 | CN1201790C Chinese medicine powder for treating diabetes II |
| 05/18/2005 | CN1201766C External use plaster for curing cervical spondylopathy |
| 05/18/2005 | CN1201765C Chinese medicine ointment for treating arthrosis |
| 05/18/2005 | CN1201760C Soft capsule for treating coronary disease and stenocardia and process for preparing same |
| 05/18/2005 | CN1201750C Oculentum for treating eye disease and preparing method thereof |
| 05/18/2005 | CN1201749C Vaginal delivery of bisphosphonates |
| 05/18/2005 | CN1201748C Method for the production of polyvinylpyrrolidone-iodine in an aqueous solution |
| 05/18/2005 | CN1201747C External applied medicine composition containing vitamin B |
| 05/18/2005 | CN1201746C Erigeron breviscapus liposome and its freeze dried powder injection and preparation method |
| 05/18/2005 | CN1201744C Rinsing liquid for treating endometritis and its preparation method |
| 05/18/2005 | CN1201739C Slow-release medicine system of compound rifampicin |
| 05/18/2005 | CN1201738C Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
| 05/18/2005 | CN1201736C Slow-releasing metronidazole prepn for position of colon |
| 05/18/2005 | CN1201732C Oral pharmaceutical forms of administration with a delayed action |
| 05/18/2005 | CN1201731C Medicine preparation and its use and the use of high grade primary alcohol mixture |
| 05/18/2005 | CN1201729C Matrices formed of polymer and hydrophobic compounds for use in drug delivery |
| 05/18/2005 | CN1201728C Incorporation of active substances in carrier matrixes |
| 05/17/2005 | US6894140 adhesive composition comprising at least one NCO-terminated hydrophilic urethane prepolymer; applying the adhesive composition over a defect in lung tissue |
| 05/17/2005 | US6894136 Mold inhibitor integrated within a matrix and method of making same |
| 05/17/2005 | US6894071 Medical compositions for intravesical treatment of bladder cancer |
| 05/17/2005 | US6894066 Magnesium salt of S-omeprazole |
| 05/17/2005 | US6893665 Tetracycline derivatives that are not removed from the gastro-intestinal tract via absorption, therefore having minimal systemic exposure and accompanying side effects in cancer therapy |
| 05/17/2005 | US6893664 Particle delivery techniques |
| 05/17/2005 | US6893662 Comprises methacrylic acid-methyl methacrylate copolymer layers for drug delivery to gastrointestinal tract |
| 05/17/2005 | US6893661 Hydrophobic ethylcellulose and hydrophillic hydroxyethyl-cellulose and/or hydroxypropyl methylcellulose; one a day tablets; consistent, reproducible delivery in presence of food; simple, inexpensive manufacturing |
| 05/17/2005 | US6893660 Stable pharmaceutical compositions without a stabilizer |
| 05/17/2005 | US6893659 Pharmaceutical composition for oral administration of a N-piperidino-3- pyrazolecarboxamide derivative, its salts and their solvates |
| 05/17/2005 | US6893658 Active vitamin D3; light and heat stability; oily solution in shell comprised of gelatin, titanium oxide with yellow and/or red iron oxide |
| 05/17/2005 | US6893657 Vehicle for ballistic administration of a bioactive material to subcutaneous and intradermal tissue, the delivery vehicle being sized and shaped for penetrating the epidermis. The delivery vehicle further comprises a stabilizing polyol glass |
| 05/17/2005 | US6893656 Athletic patch |
| 05/17/2005 | US6893655 Drug delivery |
| 05/17/2005 | US6893654 Two-stage transmucosal medicine delivery system for symptom relief |
| 05/17/2005 | US6893652 Comprises moxidectin, praziquantel, benzyl alcohol, ethanol, colloidal silicon dioxide, surfactant, and oil; veterinary medicine |
| 05/17/2005 | US6893645 Process to make a sustained release formulation |
| 05/17/2005 | US6893635 Therapeutic treatment of upper respiratory infections using a nasal spray |
| 05/17/2005 | US6893634 Without inflammatory or other immune response side effects; injection or implantation in tissue containing cancer growth; porous cellulose sulphate and polydimethyldiallylammonium membrane; breast and/or pancreatic tumors |
| 05/17/2005 | US6893628 Aerosol formulations containing P134a and particulate medicament |
| 05/17/2005 | US6893589 Process for producing granules |
| 05/17/2005 | US6893493 Preparation method of solvent-free water-dispersible hydroxypropyl methyl cellulose phthalate nanoparticle |
| 05/17/2005 | US6893431 Medical device for delivering patches |
| 05/17/2005 | CA2486752A1 Process for the removal of porogens from temperature sensitive macroreticular polymers using steam at reduced pressure |
| 05/17/2005 | CA2350061C New controlled release bead, a method of producing the same and multiple unit formulation comprising it |
| 05/17/2005 | CA2342130C Gel-based cosmetic composition |
| 05/17/2005 | CA2305256C Mometasone furoate suspensions for nebulization |
| 05/17/2005 | CA2304987C Inhibition of an fgf-binding protein using ribozymes |
| 05/17/2005 | CA2234409C Transferrin receptor protein of moraxella |
| 05/17/2005 | CA2226870C Epidural administration of therapeutic compounds with sustained rate of release |
| 05/17/2005 | CA2121870C Controlled release drug delivery device |
| 05/17/2005 | CA2117638C Adhesive bandages, wound dressings, sutures, drapes, orthodontic rubber bands, toothbrushes, and the like |
| 05/17/2005 | CA2098915C Echo contrast agent |
| 05/12/2005 | WO2005042741A2 METHODS AND COMPOSITIONS FOR TREATING 5alpha-REDUCTASE TYPE 1 AND TYPE 2 DEPENDENT CONDITIONS |
| 05/12/2005 | WO2005042695A2 Lipoparticles comprising proteins, methods of making, and using the same |
| 05/12/2005 | WO2005042600A2 High molecular weight polymers, devices and method for making and using same |
| 05/12/2005 | WO2005042539A1 Tocopherol-modified therapeutic drug compounds |
| 05/12/2005 | WO2005042510A1 Tocopheryl polyethylene glycol succinate articles and process for preparing tpgs articles |
| 05/12/2005 | WO2005042219A1 Method of forming particles |
| 05/12/2005 | WO2005042142A2 Thermosensitive, biocompatible polymer carriers with a variable physical structure for treatment, diagnosis and analysis |
| 05/12/2005 | WO2005042055A2 Transdermal drug delivery device |
| 05/12/2005 | WO2005042054A2 Pretreatment method and system for enhancing transdermal drug delivery |
| 05/12/2005 | WO2005042051A2 Method for transdermal delivery of permeant substances |
| 05/12/2005 | WO2005042026A1 Water-based composition undergoing reversible thermogelation |
| 05/12/2005 | WO2005042024A1 Stable pharmaceutical composition comprising granulocyte-colony stimulating factor |
| 05/12/2005 | WO2005042023A1 Composite material comprising a porous semiconductor impregnated with an organic substance |
| 05/12/2005 | WO2005041989A1 Topical agent and use of potassium antimonyl tartrate for preparing said agent |
| 05/12/2005 | WO2005041987A1 Polymerizable emulsions for tissue engineering |
| 05/12/2005 | WO2005041980A1 Soft steroid compositions for use in dry powder inhalers |
| 05/12/2005 | WO2005041977A2 Process for producing injectable gabapentin compositions |
| 05/12/2005 | WO2005041976A2 Injectable gabapentin compositions |
| 05/12/2005 | WO2005041968A2 Once-a-day, oral, controlled-release, oxycodone dosage forms |
| 05/12/2005 | WO2005041967A1 Transdermal preparations and method for relieving side effects in pergolide therapy |